The TNF Paradox in Cancer Progression and Immunotherapy

被引：201
作者：
Montfort, Anne [1 ]
Colacios, Celine [1 ,2 ]
Levade, Thierry [1 ,2 ,3 ]
Andrieu-Abadie, Nathalie [1 ]
Meyer, Nicolas [1 ,2 ,4 ,5 ]
Segui, Bruno [1 ,2 ]
机构：
[1] CRCT, INSERM, UMR 1037, Toulouse, France
[2] Univ Toulouse III Paul Sabatier, Toulouse, France
[3] CHU Purpan, Inst Federatif Biol, Lab Biochim, Toulouse, France
[4] Inst Univ Canc IUCT O, Dermatol, Toulouse, France
[5] CHU Toulouse, Toulouse, France
来源：
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词：
tumor necrosis factor (TNF); PD-1; CTLA-4; melanoma; immune escape; TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ISOLATED LIMB PERFUSION; RENAL-CELL CARCINOMA; FACTOR-ALPHA; MELANOMA; EXPRESSION; INHIBITOR; INFLIXIMAB; PHENOTYPE;
D O I：
10.3389/fimmu.2019.01818
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：5
相关论文
共 37 条
  • [1] Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
    Arnott, CH
    Scott, KA
    Moore, RJ
    Robinson, SC
    Thompson, RG
    Balkwill, FR
    [J]. ONCOGENE, 2004, 23 (10) : 1902 - 1910
  • [2] TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
    Bertrand, Florie
    Montfort, Anne
    Marcheteau, Elie
    Imbert, Caroline
    Gilhodes, Julia
    Filleron, Thomas
    Rochaix, Philippe
    Andrieu-Abadie, Nathalie
    Levade, Thierry
    Meyer, Nicolas
    Colacios, Celine
    Segui, Bruno
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [3] Blocking Tumor Necrosis Factor a Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma
    Bertrand, Florie
    Rochotte, Julia
    Colacios, Celine
    Montfort, Anne
    Tilkin-Mariame, Anne-Francoise
    Touriol, Christian
    Rochaix, Philippe
    Lajoie-Mazenc, Isabelle
    Andrieu-Abadie, Nathalie
    Levade, Thierry
    Benoist, Herve
    Segui, Bruno
    [J]. CANCER RESEARCH, 2015, 75 (13) : 2619 - 2628
  • [4] A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
    Brown, E. R.
    Charles, K. A.
    Hoare, S. A.
    Rye, R. L.
    Jodrell, D. I.
    Aird, R. E.
    Vora, R.
    Prabhakar, U.
    Nakada, M.
    Corringham, R. E.
    DeWitte, M.
    Sturgeon, C.
    Propper, D.
    Balkwill, F. R.
    Smyth, J. F.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (07) : 1340 - 1346
  • [5] Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
    Calcinotto, Arianna
    Grioni, Matteo
    Jachetti, Elena
    Curnis, Flavio
    Mondino, Anna
    Parmiani, Giorgio
    Corti, Angelo
    Bellone, Matteo
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188 (06) : 2687 - 2694
  • [6] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS
    CARSWELL, EA
    OLD, LJ
    KASSEL, RL
    GREEN, S
    FIORE, N
    WILLIAMSON, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) : 3666 - 3670
  • [7] TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
    Cervera-Carrascon, V.
    Siurala, M.
    Santos, J. M.
    Havunen, R.
    Tahtinen, S.
    Karell, P.
    Sorsa, S.
    Kanerva, A.
    Hemminki, A.
    [J]. ONCOIMMUNOLOGY, 2018, 7 (05):
  • [8] The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
    Charles, Kellie A.
    Kulbe, Hagen
    Soper, Robin
    Escorcio-Correia, Monica
    Lawrence, Toby
    Schultheis, Anne
    Chakravarty, Probir
    Thompson, Richard G.
    Kollias, George
    Smyth, John F.
    Balkwill, Frances R.
    Hagemann, Thorsten
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) : 3011 - 3023
  • [9] Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
    Curnis, F
    Sacchi, A
    Borgna, L
    Magni, F
    Gasparri, A
    Corti, A
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (11) : 1185 - 1190
  • [10] Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T-Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
    Donia, Marco
    Andersen, Rikke
    Kjeldsen, Julie W.
    Fagone, Paolo
    Munir, Shamaila
    Nicoletti, Ferdinando
    Andersen, Mads Hald
    Straten, Per Thor
    Svane, Inge Marie
    [J]. CANCER RESEARCH, 2015, 75 (18) : 3747 - 3759
1234